Cite Filings / STLN / 0001950047-25-009004
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
144

Sale of Securities

Starling Oncology, Inc. · Filed 2025-11-18 · Acc 0001950047-25-009004

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2025-12-15 144 Sale of Securities
  • 2025-11-20 SCHEDULE 13D/A Beneficial Ownership Report
  • 2025-11-19 4 Chief Executive Officer acquired 6,464 shares (grant or award)
  • 2025-11-19 4 Chief Medical Officer acquired 2,086 shares (grant or award)
  • 2025-11-19 4 Chief Financial Officer acquired 195 shares (grant or award)
  • 2025-11-18 144 Sale of Securities
  • 2025-06-05 144 Sale of Securities

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…